Stratec SE Asset Resilience Ratio
Stratec SE asset resilience ratio. Stratec SE (SBS) has an Asset Resilience Ratio of 0.29% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Stratec SE to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Stratec SE (2008–2025)
Asset resilience ratio of Stratec SE from 2008 to 2025. This chart shows how Stratec SE's Asset Resilience Ratio has changed over time. Read Stratec SE total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Stratec SE's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Stratec SE (SBS) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €1.19 Million | 0.29% |
| Total Liquid Assets | €1.19 Million | 0.29% |
Asset Resilience Insights
- Limited Liquidity: Stratec SE maintains only 0.29% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Stratec SE Industry Peers by Asset Resilience Ratio
Compare Stratec SE's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 26.03% |
|
Paxman AB
ST:PAX |
Medical Devices | -3.83% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd
TA:PULS |
Medical Devices | 51.61% |
|
Geratherm Medical AG
XETRA:GME |
Medical Devices | 34.89% |
Stratec SE Asset Resilience Ratio by Year (2008–2025)
Stratec SE asset resilience ratio by year from 2008 to 2025. The table below shows the annual Asset Resilience Ratio data for Stratec SE.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.30% | €1.34 Million ≈ $1.57 Million |
€443.38 Million ≈ $518.36 Million |
-0.05pp |
| 2024-12-31 | 0.35% | €1.56 Million ≈ $1.83 Million |
€445.06 Million ≈ $520.32 Million |
+0.20pp |
| 2023-12-31 | 0.15% | €683.00K ≈ $798.50K |
€466.58 Million ≈ $545.48 Million |
-0.21pp |
| 2022-12-31 | 0.35% | €1.40 Million ≈ $1.64 Million |
€397.50 Million ≈ $464.72 Million |
-0.06pp |
| 2021-12-31 | 0.42% | €1.54 Million ≈ $1.80 Million |
€368.52 Million ≈ $430.84 Million |
-0.06pp |
| 2020-12-31 | 0.48% | €1.59 Million ≈ $1.85 Million |
€331.90 Million ≈ $388.03 Million |
-7.55pp |
| 2019-12-31 | 8.02% | €24.03 Million ≈ $28.09 Million |
€299.41 Million ≈ $350.05 Million |
-0.92pp |
| 2018-12-31 | 8.95% | €24.63 Million ≈ $28.79 Million |
€275.29 Million ≈ $321.84 Million |
-4.94pp |
| 2017-12-31 | 13.89% | €36.63 Million ≈ $42.83 Million |
€263.78 Million ≈ $308.38 Million |
+1.56pp |
| 2016-12-31 | 12.33% | €31.81 Million ≈ $37.19 Million |
€257.97 Million ≈ $301.59 Million |
+10.58pp |
| 2015-12-31 | 1.75% | €2.78 Million ≈ $3.25 Million |
€158.94 Million ≈ $185.82 Million |
+1.11pp |
| 2014-12-31 | 0.64% | €877.00K ≈ $1.03 Million |
€137.75 Million ≈ $161.04 Million |
+0.09pp |
| 2013-12-31 | 0.55% | €646.00K ≈ $755.24K |
€117.79 Million ≈ $137.71 Million |
+0.25pp |
| 2012-12-31 | 0.30% | €366.00K ≈ $427.89K |
€121.84 Million ≈ $142.44 Million |
+0.10pp |
| 2011-12-31 | 0.20% | €222.39K ≈ $259.99K |
€111.00 Million ≈ $129.77 Million |
-0.33pp |
| 2010-12-31 | 0.53% | €526.22K ≈ $615.21K |
€98.84 Million ≈ $115.55 Million |
-0.23pp |
| 2009-12-31 | 0.76% | €653.79K ≈ $764.35K |
€85.79 Million ≈ $100.29 Million |
+0.34pp |
| 2008-12-31 | 0.42% | €292.78K ≈ $342.29K |
€69.97 Million ≈ $81.80 Million |
-- |
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and softwar… Read more